{"id":"https://openalex.org/A5069717819","orcid":null,"observed_orcids":[],"display_name":"Reiko Ikegami","raw_author_names":["R Ikegami","Reiko IKEGAMI","Reiko Ikegami"],"full_name":"Reiko Ikegami","works_count":7,"cited_by_count":267,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":5,"i10_index":5},"ids":{"openalex":"https://openalex.org/A5069717819","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I22299242","ror":"https://ror.org/02kpeqv85","display_name":"Kyoto University","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]},"years":[2003,2001,1999,1998]},{"institution":{"id":"https://openalex.org/I4210087238","ror":"https://ror.org/0059xpe44","display_name":"Kaken Pharmaceutical (Japan)","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210087238"]},"years":[2011]}],"last_known_institutions":[{"id":"https://openalex.org/I4210087238","ror":"https://ror.org/0059xpe44","display_name":"Kaken Pharmaceutical (Japan)","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210087238"]}],"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","count":5,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","count":4,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","count":3,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10222","display_name":"Genomics and Chromatin Dynamics","count":2,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","count":2,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","value":4.3e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","value":2.33e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","value":2.08e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","value":7.8e-06,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10960","display_name":"Hypothalamic control of reproductive hormones","value":7.3e-06,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"178592051","wikidata":"https://www.wikidata.org/wiki/Q28208812","display_name":"Prostaglandin E2 receptor","score":0.9753936529159546},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.8122118711471558},{"id":"134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","score":0.8120115399360657},{"id":"2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","score":0.6694869995117188},{"id":"170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","score":0.6333385109901428}],"counts_by_year":[{"year":1998,"works_count":2,"oa_works_count":1,"cited_by_count":0},{"year":1999,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2001,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2003,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2004,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2011,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":16},{"year":2013,"works_count":0,"oa_works_count":0,"cited_by_count":13},{"year":2014,"works_count":0,"oa_works_count":0,"cited_by_count":10},{"year":2015,"works_count":0,"oa_works_count":0,"cited_by_count":7},{"year":2016,"works_count":0,"oa_works_count":0,"cited_by_count":2},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":4},{"year":2018,"works_count":0,"oa_works_count":0,"cited_by_count":4},{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":4},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":9},{"year":2021,"works_count":0,"oa_works_count":0,"cited_by_count":5},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":3},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":5},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":5}],"display_name_alternatives":["R Ikegami","Reiko IKEGAMI","Reiko Ikegami"],"block_key":"r ikegami","works_api_url":"https://api.openalex.org/works?filter=author.id:A5069717819","updated_date":"2026-10-31T12:29:50","created_date":"2025-10-10T00:00:00"}